Healthcare

Joint Pain Injections Market Size, Trends, Analysis And Forecast 2024-2033 | Seikagaku Corporation, Flexion Therapeutics Inc., Zimmer Biomet Holdings Inc., Sanofi S.A., Anika Therapeutics Inc

The Joint Pain Injections Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Joint Pain Injections Market:

https://www.thebusinessresearchcompany.com/report/joint-pain-injections-global-market-report

According to The Business Research Company’s Joint Pain Injections Global Market Report 2024, The joint pain injections market size has grown rapidly in recent years. It will grow from $5.19 billion in 2023 to $5.75 billion in 2024 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to increased aging population, arthritis prevalence, global health initiatives, healthcare digitalization, increasing awareness of chronic pain management.

The joint pain injections market size is expected to see rapid growth in the next few years. It will grow to $8.8 billion in 2028 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to expansion of telehealth services, personalized pain management, patient education and empowerment, sustainable healthcare practices, nutritional support. Major trends in the forecast period include regenerative medicine, personalized pain management, innovative injection materials, rehabilitation technologies, artificial intelligence ai-enhanced injections.

The rise in the prevalence of arthritis and musculoskeletal disorders will propel the growth of the joint pain injections market. Musculoskeletal disorders are the biggest cause of disability worldwide, with low back pain being the single most common cause of impairment in 160 nations. Patients are taking injections for pain relief and inflammatory condition. For instance, in February 2021, according to the report published by WHO, approximately 1.71 billion people in the world are affected by musculoskeletal conditions and the number of people with musculoskeletal disorders is continuously growing due to population growth and aging. Similarly, in 2021, according to the report by Global RA Network, arthritis affects about 350 million people worldwide and increasing rapidly. Therefore, the rising prevalence of arthritis and musculoskeletal disorder drives the joint pain injections market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=6482&type=smp

The joint pain injections market covered in this report is segmented –

1) By Type Of Injection: Steroid Joint Injection, Hyaluronic Acid Injections, Platelet-Rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Other Type Of InjectionS

2) By Joint Type: Hip Joint, Knee And Ankle, Shoulder And Elbow, Facet Joints Of The Spine, Other Joint Types

3) By Distribution channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

New product development is a key trend gaining popularity in the joint pain injections market. Major companies operating in the join pain injections sector are focused on new product innovations to meet consumer demand and strengthen their position. In September 2021, Contura International Ltd., a UK-based manufacturer of innovative therapeutic hydrogels, launched Arthrosamid. Arthrosamid is an innovative hydrogel injection for knee osteoarthritis that uses non-biodegradable hydrogel technology, offers an alternative to existing treatments, satisfies a clinical need for a potent, long-lasting, secure, and minimally intrusive method of treating knee osteoarthritis pain (OA).

The joint pain injections market report table of contents includes: